Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00364676

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkins Disease, +10 more
Locations
  • Cancer Therapy and Research Center San Antonio, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • McGill Centre for Translational Research in Cancer-Jewish General Hospital Clinical Research Unit Montreal, Quebec, Canada
View Trial Details
Completed

Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

NCT02544789

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Department of Pediatrics, Peking University People's Hospital Beijing, China
  • Department of Phase 1 Clinical Trial, Peking University People's Hospital Beijing, China
  • Guangdong General Hospital, Guangdong Academy of Medical Science Guangzhou, China
  • The First Affiliated Hospital, Zhejiang University Hangzhou, China
View Trial Details
Completed

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

NCT00144755

Conditions
Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Université de Gent Ghent, Belgium
  • Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
  • Polyclinique Bordeaux Nord Bordeaux, France
  • Hôpital Henri Mondor Créteil, France
View all 14 locations
View Trial Details
Completed

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

NCT00169195

Conditions
Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hôpital Henri Mondor Créteil, France
  • Service d'Hématologie Clinique - CHU Le Bocage Dijon, France
  • Service des Maladies du Sang - CHRU de Lille Lille, France
  • Centre Léon Bérard Lyon, France
View Trial Details
Completed

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

NCT00144807

Conditions
Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
  • Polyclinique Bordeaux Nord Bordeaux, France
  • Hôpital Henri Mondor Créteil, France
  • Hématologie CHU de Lille Lille, France
View all 13 locations
View Trial Details
Completed

Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

NCT01236391

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Cll Research and Treatment Program New Hyde Park, New York, United States
  • New York Presbyterian Hospital/Cornell Medical Center New York, United States
View all 18 locations
View Trial Details

Related conditions